Mayo Clinic in Florida names VP
The Mayo Clinic Board of Trustees has named Dr. Gianrico Farrugia Mayo vice president and announced he will become CEO of Mayo's Florida campus in Jacksonville.
Farrucia will succeed Dr. William Rupp, who plans to retire at the end of the year.
"Dr. Farrugia brings a wealth of experience to his new role," Mayo president and CEO Dr. John Noseworthy said. "He is a physician-leader who brings to this important role a deep commitment to Mayo's values, mission and strategic vision, along with a passion to lead and equip teams to reach more patients and strengthen Mayo Clinic's position as a global health care leader."
Farrugia has served at Mayo on the Rochester campus in gastroenterology, hepatology, and physiology and biomedical engineering divisions for more than 26 years.
He's a professor of medicine, physiology and biomedical engineering.
Farrugia has held multisite leadership roles in his specialty and at the organizational level.
He is currently director of the Mayo Clinic Center for Individualized Medicine and director of the Mayo Clinic Enteric Neuroscience Program. He also previously served as research chair of the Department of Medicine.
Farrugia work in concert with Florida Chief Administrative Officer Brigham"to provide leadership and direction, defining and implementing Mayo Clinic's operational plan and continuing to expand Mayo Clinic's leadership and reach in the Southeast and beyond," says the Mayo announcement.
"Dr. Farrugia is a tremendously talented, proven and energetic leader," said Dr. Rupp, who has been Florida since 2008. "His overall vision for the Florida campus and his creative ideas for seeking new ways to improve the way we deliver high-quality health care to our patients will make for a very bright future for our campus and Mayo Clinic."
Farrugia assumes his new role on Jan. 1 after a transition period when both Rupp and Farrugia will be at the Florida campus.
"We deeply appreciate Dr. Rupp's commitment to our patients, staff and communities during his distinguished career at Mayo Clinic," Noseworthy emphasized. "He has brought compassion, discipline, optimism and a focus on operational excellence to his leadership roles at the local, regional and enterprise level. Dr. Rupp is a valued colleague and friend, and we wish him well in retirement. I know our entire Mayo Clinic staff joins me in congratulating Dr. Farrugia on his new role and in thanking Dr. Rupp for his many contributions."
The Board of Trustees also recognized four new named professorships, the highest academic distinction for faculty members at Mayo Clinic, during its quarterly meeting Friday. They include:
• Dr. Michael Brodsky, a physician with joint appointments in the Department of Neurology and Department of Ophthalmology; the Knights Templar Eye Foundation, Inc. Professorship in Ophthalmology Research.
• Dr. Douglas Husmann, Department of Urology; the Anson L. Clark Professor in Urology.
• Dr. Kerry D. Olsen, chair of the Division of Head and Neck Surgery in the Department of Otolaryngology; the Joseph I. and Barbara Ashkins Professor in Surgery.
• Dr. Ulrich Specks, chair of the Division of Pulmonary and Critical Care Medicine within the Department of Internal Medicine; the Connor Group Foundation Professor in Thoracic Diseases Honoring Dr. Claude Deschamps and Dr. Eric Edell.